An
Assessment of Neonatal Status Using Apgar score: Pipecuronium Bromide Used as an Anaesthesia
Drug during Caesarian-Section
Dhruv
V.K.1, Sahu A.2 Bansal A.K.3, Shashikala
Dhruv (Thakur)4,
Shrivastav P.K.3, Baghel
B.2, Viswanadham K. K.2 and
Sharma S.5
Dept. of Anaesthesia1, Paediatrics2,
Community Medicine3,
Pathology4 and
Pharmacology5, Govt.
Medical College, Jagdalpur (BASTAR) -494001 -INDIA
ABSTRACT:
Objectives: To know the effects of Pipecuronium
Bromide used as general anaesthesia during caesarian
section on neonates, if any? Material and Methods: Eighty five mothers who have
undergone Caesarian Section were included in the study (sixty five in study and
twenty in control group). Statistical analysis: Chi-square tests, Proportion
etc. were used for statistical analysis. Results: 85% had an average apgar score of 9.19 and 9.92 at 1 minute and 5 minutes
interval. Only 15% had an average Apgar score of 5.77
to 8.0. Preoperative foetal distress and prematurity
were the two factors leading to a poor scoring.
Conclusion: It was concluded that pipecuronium
Bromide can be used safely during Caesarian Section without any adverse effects
on Neonates.
KEYWORDS: Apgar score,
Caesarian-Section, New-borne.
INTRODUCTION:
For Caesarean Section (C-section) to provide optimal anaesthesia, causing least trespass in to the existing patho-physiology of the mother and the child, needs the use
of such techniques and drug, which have minimal side effects. The Anaesthesiologist has to be sound as regards the changes in
the mother during pregnancy and labour, direct or
indirect effect of the drug on mother and neonate, the benefit and rest of
various anaesthetic technique and drugs for the
proper anaesthetic management of the C-section. There
is a long list of drugs and recently pipecuronium
bromide has been added to this list of non depolarizing muscle relaxants having
longer duration of action than the existing ones. As no and /or very face
reports of clinical study of this drug on foetal out
come after C-section is available in literature and in 1957 a study group of
World Health Organization W.H.O. has expressed the view that in order to get a
comprehensive picture of disease (drug used) more and more studies have to be
conducted Garg Narendra K.
(1). This prompted us to undertake this study which is primarily aimed at
assessing safety of pipecuronium bromide as a muscle
relaxant in balanced general anaestesia during
C-section vis
- a vis foetal (Neonate)
out come by using APGAR SCORE .
MATERIAL
AND METHODS:
The present study was conducted in the Dept. of Anaesthesiology, G.M. Hospital and S.S. Medical College, Rewa, 85 patients were divided in to two groups, study and
control. In study group 65 patients and in control 20 patients were included.
All the patients were weight beforehand to determine the dose of drug /Kg. body
weight.
The study group received Pipecuronium
0.08 mg /Kg. of body weight and control group spinal anaesthesia,
Xylocaine 5%, 1 2 ml.
APGAR SCORING SYSTEM: - This scoring system was
developed by VIRGINIA 1953. Since then it has been widely used to decide in
whether immediate resuscitation is required or not. It is a practical method of
systematically assessing the newborn infant immediately after birth.
The principal of giving a score to a patient as sum
total of several objective finding is not new and has been used recently in
judging the treatment of drugs addition. The end point which has been used
previously in field of resuscitation is breathing time, defined as the time
from delivery to the establishment of a satisfactory cry.
A list was made of all the objective signs which
pertained in any way to the condition of the infant at birth. Of these five
signs which could be determined easily and without interfering with the care of
the infant were considered useful, a rating of zero, one or two, was given to
each sign depending, whether it is absent or present. A score of ten indicated
baby in the best possible condition.
These ratings have been included in the present series.
The signs are used as
follows:-
1. Heart rate: This was found to be the most
important diagnostic and prognostic of the five signs. A heart rate of 100-140
was considered good and given a score of two. A rate under 100 received a score
of one, and if no rate could be seen, felt or heard the score was zero. The epigastrium or precordium can be
observed for visible heart beat, while palpation of the cord about two inches
from the umbilicus is the most satisfactory method for determining the heart
rate quickly.
2. Respiratory Effort: An infant who was apnoeic at 60 seconds after birth received a score of zero.
While one who breathed and cried lustily received a two rating. All other type
of respiratory effort such as irregular, shallow ventilation was scored one. An
infant who had gasped once in thirty or fourty five
seconds after birth, and who then became apnoeic,
received zero.
3. Reflex Irritability: This term refers to the
response to some form of stimulation. The usual testing method was suctioning
the oropharynx and nares
with a soft rubber catheter which called forth a response of facial grimace,
sneezing or coughing.
4. Muscle Tone : This was an easy sign to
judge, for a completely flaccid infant received a zero score and one with good
tone and spontaneously flexed arms and legs which resisted extension were rated
two point .We are unable to agree with flaggs descripition of
spasticity as a sign of asphyxiation of the infant. The use of
analeptics in the baby did not influence this score because of the standardized
early time of observation and rating.
5. Color: This is by the most unsatisfactory
sign and caused the most discussion among the observers. All infants are
obviously cyanotic at birth because of their high capacity for carrying oxygen
and their relatively low oxygen content and saturation. The disappearance of
cyanosis depends directly on two sign previously considered respiratory effort
and heart rate.
Comparatively few infant were given a full score of two
for this sign, and many received zero. The foreign material so often covering
the skin of the infant at birth interfered with interpreting this sign, as did
the inherited pigmentation of the skin of colored children, and an occasional
congenital defect.
Thus each criterion is given a score of 0, 1, or 2
based on whether the response to testing that criterion is absent or grossly
abnormal - 0, mediocre or slightly abnormal - 1; or normal - 2. Therefore the
maximum possible score is 40.
RESULTS:
On analysis of collected data it has been revealed that
the mean weight of the infants in both groups was approximately same. Apgar score 7 to 10 was considered to be vigorous infant,
in the both group there was an insignificant difference in the Apgar at 5 minutes (P< 0.01) (Table 1). It has been
further revealed that there was no statistical significant difference in mean Apgar score at 1and 5 minute interval of both group
(<0.01). Regarding newborn cry, again an insignificant difference was noted
in both group (P < 0.01).
Table No. I Mean birth
weight, Newbornes crying time and Apgar
scores.
S. No. |
Data |
Study Group |
Control Group |
1 |
Mean birth weight |
2.83 ± .56 |
2.66 ± 2.31 |
2 |
New-bornes crying time (in sec. ± mean S.D.) |
14.21 ± 4.46 |
14.12 ± 4.31 |
3 |
Mean Apgar Score ± S.D. |
|
|
at 1 min. |
8.86 ± 1.61 |
8.72 ± 1.32 |
|
at 5min. |
9.63 ± 1.66 |
9.8 ± .63 |
|
4 |
Apgar score (7-10) |
|
|
at 1 min. |
78.6% |
92% |
|
at 5min. |
100% |
100% |
Table further reveals that the mean Apgar score at
1 minute and 5 minutes interval of both (Study and Control) group, there is no
statistically significant difference in the Apgar
score of both the group (P<0.01). Table also shows 14.21 ± 4.46 in study
group was comparable with the control group 14.21 ± 4.31 the P value of this
was P<0.01 showing an insignificant difference in both groups.
Neonatal Outcome: - No evidence of adverse effect on neonates
with pipecuronium were found in this study and also
no clinical evidence of myoneural blockade in infant,
whose mothers had received pipecuronium bromide
before delivery. These conclusions were based on Apgar
scores and general observations.
Table No. II Apgar score at 1 min., 5 min. used of pancuronium,
Vecuronium, Atracuonium
study drug pipecurinum in C.S.
S. N. |
Author |
Year |
Drug studied and its dose |
Apgar
at min. ± S.D. |
Apgar
at 5 min. S.D. |
1. |
Spiers et. al |
1972 |
Pancuronium 0.07-0.1mg./ kg |
-- |
9 ± 0.4 |
2. |
Neel et. al. |
1973 |
Pancuronium 0.87 mg./ kg |
7.2 ± 1.9 |
9 ± 0.4 |
3. |
Booth et. al. |
1977 |
Pancuronium 0.08-0.01 mg./ kg |
6.1 |
9.6 |
4. |
Duraldest in et. al. |
1978 |
Pancuronium0.05-0.08 mg./ kg |
8.5 ± 08 |
9.8 + 0.1 |
5. |
Mazumder et. al. |
1983 |
Pancuronium 1
mg./ kg |
8.12 ± 1.2 |
9.24 ± 0.91 |
6. |
Baraka et. al. |
1983 |
Vecuronium 0.05 mg./ kg |
100% > 7 |
100% > 7 |
7. |
Dailey et. al. |
1984 |
Pancuronium 0.04 mg./ kg |
57% > 8 |
100% > 8 |
8. |
Dailey et. al. |
1984 |
Vecuronium 0.04 mg./ kg |
45% > 8 |
91% > 8 |
9. |
Flynn |
1984 |
Atracuronium 0.03 mg./ kg |
7.77 |
9.6 |
10. |
Dixit et. al. |
1986 |
Pencuronium 4 mg./ kg |
8.1 |
9 |
11. |
Baijal P.K. |
1988 |
Atracuronium 0.3 mg./ kg |
-- |
81.1% scored 10 |
12. |
Mayak et. al |
1988 |
Atracuronium 0.5 mg./ kg |
86% scored 9 |
86% scored 10 |
13. |
Shearea et. al. |
1991 |
Atracuronium 0.3 mg./ kg |
8.3 ± 1.67 |
9.6 ± 0.59 |
14. |
Chatterjee |
1991 |
Vencuronium 0.1 mg./ kg |
9 |
10 |
15. |
Chatterjee |
1991 |
Atracuronium 0.1mg./ kg |
8.5 |
10 |
16. |
Present study |
1996 |
Piperacuronium |
8.68 ± 1.61 |
9.23 ± 1.66 |
In the present study 9 cases showing having foetal distress pre-operative because of some reason or
others had an Apgar score less than 7 in 1 minutes
and less than 10 in 5 minutes.
DISCUSSION:
Spiral et al (3) studied effect of pancuronium
0.07 0.1 mg/kg. and found the Apgar score at 5
minutes to be 9 ± 0.4. Neld et al (1973) suxamethonium
with pancuronium sequence reported mean Apgar score at 1 minutes, 5 minutes to be 7.2 ± 1.9 and 9 ±
0.8 Booth et al (1977) used pancuronium 0.1 mg./kg.
Followed by suxamethonium and reported Apgar scores of 6.1 and 9.6 at 1 minute and 5 minutes.
Muzumdar
et al (5) utilized 0.1
mg./kg. of pancuronium for intubation and maintainence of anaesthesia
obtained an Apgar score of 8.12 at 1 minute and 9.24
at 5 minutes Barka et al (14) reported Apgar score more than 7 minutes in all neonates using vecuronium 0.05 mg./kg/ following suxamethonium
for intubation. In the study by Dailey
et al (16) using pancuronium 0.04 mg./kg.
similarly vercuronium 0.04 mg./kg. was used and 45%
neonate scored more than 8 at 1 minute, 91% scored at 8-10 at 5 minutes in the
same study.
Flynn et al (15) reported use of Atrcurium
0.3 mg./kg., for caesarean section resulting in mean Apgar
scores of 7.7 at 1 minute and 9.6 at 5 minutes, Howkins
et al (1990) reported 70% infants scoring more than 7 at 1 minute and all the
neonates scoring more than 7 at 5 minutes, after use of vercuronium
0.1 mg./kg for intubation and maintenance.
The Apgar score obtained in
our study are 8.68 ± 1.61 at 1 minute, 9.63 ± 1.66 at 5 minutes. It is
comparable to the above studies.
From the above study it was concluded that Pipecuronium can be used safely during caesarean section
without any adverse effect on the neonate for elective & emergency L.S.C.S.
ACKNOWLEDGEMENT:
The authors express their cordial thanks to Mr. Anand Singh Kanwar,
Lab-Technician, Dept. of Community Medicine, Govt. Medical College, Jagdalpur (C.G.) for his neat and excellent typing.
REFERENCES:
1. Garg Narendra K.
Evaluation of the impact of emesis and emesis plus purgation therapy; Research
J. Pharmacology and Pharmacodynamics: 2 (2) March April 2010; 201-202.
2. Apgar V. A proposal for a new method of
evaluation of the newborne infant. Anaesth. Analg. Curr. Resp. 1953; 33:260.
3. Spiers I. et al. The placental Transfer of pan curonium bromide. Br. J Anaesth.
1972; 44: 370.
4. Neel J.B. A clinical Comparision
of Pancuronium and Tubocuranine
for Caesarean Section Anaesthesia. Anaesth. And Analg. Curr. Res. 1974; 53: 7.
5. Majumdar B.B. A clinical comparision
of the neonatal status following anaesthesia for
Caesarian Section, using suxamethonium as muscle
relaxant in one series and pancuronium in the other
Indian J. Anaesth. 1983; 31: 31.
6. Bansal A.K. and Chandorkar
R.K. (1993) knowledge, Belief and Practice: A study of Tribal mothers about
feeding of infants; Tribal Health Bulletine (ICMR);
Vol. 2, No. 3 & 4: 1-2.
7. Bansal A.K. and Chandorkar
R.K. (1993) effectiveness of ICDS in child care in Rural and Tribal areas of
Chhattisgarh (M.P.) J. Ravi Shankar uni; Vol. 6,
No.-B (Science) 61-65.
8. Bansal A.K. and Saxena
V.B.(2000) impact of I.C.D.S. on Pregnancy pattern of Tribal and Non Tribal
women. J. Ravi Shankar uni; Vol. 13, No.-B
(Science) 54-58.
9. Bansal A.K. and Chandorkar
R.K. (1993) utilization of Health Care delivery by Tribal and Non Tribal women
of an ICDS block (1993) J. Ravi Shankar uni; Vol.-6,
No.-B (Science) 57-60.
10. Bansal A.K., Agarwal
Ashok K. and Govila A.K. (1998-99) Status of girl
child amongst Tribal and Non Tribal in the unreached rural India; J. Ravi
Shankar uni; Vol. 11-12, No.-B (Science) 31-36.
11. Bansal A.K. and Agarwal
A.K. (1994) impact of training the knowledge of Tribal and Non Tribal Anganwade workers; J. Ravi Shankar uni;
Vol. 7, No.-B (Science) 51-54.
12. Bansal A.K. and Chandorkar
R.K. (1997) Immunization status of Tribal and Non Tribal Children of Raipur
district, Madhya Pradesh; Tribal Health Bulletin (ICMR) Vol. 3, No.-2; 12-14.
13. Bansal A.K. and Chandorkar
R.K. Impact of I.C.D.S. on morbidity due to Nutritional deficiency Diseases
amongst Tribe and Non Tribe Children; Research J Science and Tech.; 2009: 1(2);
82-84.
14. Baraka A. et. al.: Succinylcholine
Vecuronium sequence for caesarean-section. Anaesth. Analg.; 1983; 62;903.
15. Flynn P.J. et. al.: Use of atracurium in caesarean-section, Br. J. Anesth.
1984; 56; 599.
16. Dailey P.A. et. al.: Pharmacokinetics
placental transfer and neonatal effects of vecuronium
and pancuronium administered during caesarean-section
Anesthesiology 1984; 60; 569.
Received on 24.02.2011
Modified on 18.04.2011
Accepted on 04.07.2011
© A&V Publication all right reserved
Research J.
Science and Tech. 3(4): May-June. 2011: 189-191